How many pathways are there to nigral death?

Annals of Neurology

Volumn 56, Issue 3, 2004, Pages 316-318

  Hardy, John ^a   Langston, J William ^b  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b PARKINSON S INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; DOPAMINE; PARKIN;

AUTOSOMAL RECESSIVE DISORDER; CELL DEATH; DOPAMINERGIC NERVE CELL; EDITORIAL; GENE IDENTIFICATION; GENOTYPE; HUMAN; NEUROLOGIC DISEASE; NEUROPATHOLOGY; PARKINSON DISEASE; PARKINSONISM; PHENOTYPE; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

ANIMALS; CELL DEATH; HUMANS; MUTATION; NEURAL PATHWAYS; PARKINSON DISEASE; SUBSTANTIA NIGRA;

EID: 4444231730     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20257     Document Type: Editorial

References (25)

1. Hornykiewicz O. Dopamine miracle: from brain homogenate to dopamine replacement. Mov Disord 2002;17:501-508.
2. Coyle JT, Price DL, DeLong MR. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 1983;219: 1184-1190.
3. Hardy J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci 1997;20:154-159.
4. Valente EM, Abou-Sleiman PM, Caputo V, et al. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 2004;304:1158-1160.
5. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997;276:2045-2047.
6. Kitada T, Asakawa S, Hattori N, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998;392:605-608.
7. Bonifati V, Rizzu P, van Baren MJ, et al. Mutations in the DJ-I gene associated with autosomal recessive early-onset parkinsonism. Science 2003;299:256-259.
8. Valente EM, Salvi S, Ialongo T, et al. PINK1 mutations are associated with sporadic early-onset parkinsonism. Ann Neurol 2004;56:336-341.
9. Rohé CF, Montagna P, Breedveld G, et al. Homozygous PINK1 C terminus mutation causing early-onset parkinsonism. Ann Neurol 2004;56:427-431.
10. Hatano Y, Li Y, Sato K, et al. Novel PINK1 mutations in early onset parkinsonism. Ann Neurol 2004;56:424-427.
11. Healy DG, Abou-Sleiman PM, Ahmadi KR, et al. The gene responsible for PARK6 Parkinson's disease does not influence common forms of parkinsonism. Ann Neurol 2004;56: 329-335.
12. Golbe LI, Di Iorio G, Lazzarini A, et al. The Contursi kindred, a large family with autosomal dominant Parkinson's disease: implications of clinical and molecular studies. Adv Neurol 1999;80:165-170.
13. Muenter MD, Forno LS, Hornykiewicz O, et al. Hereditary form of parkinsonism-dementia. Ann Neurol 1998;43: 768-781.
14. Zarranz JJ, Alegre J, Gómez-Esteban JC, et al. The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 2004;55:164-173.
15. Farrer M, Maraganore DM, Lockhart P, et al. α-Synuclein gene haplotypes are associated with Parkinson's disease. Hum Mol Genet 2001;10:1847-1851.
16. Hilker R, Klein C, Ghaemi M, et al. Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene. Ann Neurol 2001;49:367-376.
17. Lucking CB, Durr A, Bonifati V, et al. Association between early-onset Parkinson's disease and mutations in the parkin gene. French Parkinson's Disease Genetics Study Group. N Engl J Med 2000;342:1560-1567.
18. Farrer M, Chan P, Chen R, et al. Lewy bodies and parkinsonism in families with parkin mutations. Ann Neurol 2001;50: 293-300.
19. West AB, Maraganore D, Crook J, et al. Functional association of the parkin gene promoter with idiopathic Parkinson's disease. Hum Mol Genet 2002;11:2787-2792.
20. Hague S, Rogaeva E, Hernandez D, et al. Early-onset Parkinson's disease caused by a compound heterozygous DJ-1 mutation. Ann Neurol 2003;54:271-274.
21. Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 2002;125:861-870.
22. Canet-Aviles RM, Wilson MA, Miller DW, et al. The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc Natl Acad Sci USA 2004;101:9103-9108.
23. Sherer TB, Betarbet R, Greenamyre JT. Environment, mitochondria, and Parkinson's disease. Neuroscientist 2002;8: 192-197.
24. Orth M, Schapira AH. Mitochondrial involvement in Parkinson's disease. Neurochem Int 2002;40:533-541.
25. Gwinn-Hardy K. Genetics of parkinsonism. Mov Disord 2002; 17:645-656.